Finance

4Q20 Wrap: Stocking up

All market cap tiers were up in 4Q and FY20

All market cap tiers were up in 4Q and FY20

Life sciences stocks continued an upward trajectory at the end of 2020, with median gains of at least 7% in 4Q20 and at least 24% over the year across all market cap tiers. Companies valued between $500-$999 million were the best performers during the last quarter with a median gain of